Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial.

By Nancy R. Cook, I. Lee, J. Gaziano, David Gordon, P. Ridker, JoAnn E. Manson, C. Hennekens, J. Buring. Journal of the American Medical Association (JAMA), 2005

786 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women. (2005, methodology): “The methods of the cohort assembly, follow-up, and end-point validation have been described previously.(19-21) All participants in the WHS provided written informed consent and the study protocol was approved by the institutional review board of the Brigham and Women’s Hospital (Boston, Mass).”
Impact of dry eye syndrome on vision-related quality of life. (2007, methodology): “19, 20 Information on general characteristics of the study population was ascertained on annual questionnaires as has been previously reported.”
Leisure Time Physical Activity of Moderate to Vigorous Intensity and Mortality: A Large Pooled Cohort Analysis (2012, methodology): “The Women’s Health Study is a two-by-two factorial clinical trial evaluating low dose aspirin and vitamin E in the prevention of cardiovascular disease and cancer among female health professionals [19–21].”
ACG Clinical Guidelines: Colorectal Cancer Screening 2021. (2021, background): “This study randomized 39,876women in theUnited States to aspirin 100 mg every other day or placebo (194).”